CAMP4 Therapeutics Corp
NASDAQ:CAMP

Watchlist Manager
CAMP4 Therapeutics Corp Logo
CAMP4 Therapeutics Corp
NASDAQ:CAMP
Watchlist
Price: 5.94 USD -1% Market Closed
Market Cap: 278.5m USD

Wall Street
Price Targets

CAMP Price Targets Summary
CAMP4 Therapeutics Corp

Wall Street analysts forecast CAMP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CAMP is 8.93 USD with a low forecast of 7.07 USD and a high forecast of 12.6 USD.

Lowest
Price Target
7.07 USD
19% Upside
Average
Price Target
8.93 USD
50% Upside
Highest
Price Target
12.6 USD
112% Upside
CAMP4 Therapeutics Corp Competitors:
Price Targets
AMGN
Amgen Inc
0% Upside
ASND
Ascendis Pharma A/S
28% Upside
688331
RemeGen Co Ltd
16% Upside
251120
Bio-FD&C Co Ltd
22% Upside
005690
Pharmicell Co Ltd
13% Upside
ALCLS
Cellectis SA
62% Upside

Revenue
Forecast

Revenue Estimate
CAMP4 Therapeutics Corp

For the last 1 year the compound annual growth rate for CAMP4 Therapeutics Corp's revenue is 86%. The projected CAGR for the next 4 years is 109%.

86%
Past Growth
109%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
CAMP4 Therapeutics Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
CAMP4 Therapeutics Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CAMP's stock price target?
Price Target
8.93 USD

According to Wall Street analysts, the average 1-year price target for CAMP is 8.93 USD with a low forecast of 7.07 USD and a high forecast of 12.6 USD.

What is CAMP4 Therapeutics Corp's Revenue forecast?
Projected CAGR
109%

For the last 1 year the compound annual growth rate for CAMP4 Therapeutics Corp's revenue is 86%. The projected CAGR for the next 4 years is 109%.

Back to Top